Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines - PubMed (original) (raw)
. 1992 Oct 15;52(20):5826-8.
doi: 10.2172/10148922.
Affiliations
- PMID: 1356621
- DOI: 10.2172/10148922
Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines
F R Collart et al. Cancer Res. 1992.
Abstract
Inosine-5'-phosphate (IMP) dehydrogenase, a regulatory enzyme of guanine nucleotide biosynthesis, may play a role in cell proliferation and malignancy. To assess this role we examined IMP dehydrogenase expression in a series of human solid tumor tissues and tumor cell lines in comparison with their normal counterparts. Increased IMP dehydrogenase gene expression was observed in brain tumors relative to normal brain tissue and in sarcoma cells relative to normal fibroblasts. Similarly, in several B- and T-lymphoid leukemia cell lines, elevated levels of IMP dehydrogenase mRNA and cellular enzyme were observed in comparison with the levels in peripheral blood lymphocytes. These results are consistent with an association between increased IMP dehydrogenase expression and either enhanced cell proliferation or malignant transformation.
Similar articles
- Regulation and role of inosine-5'-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation.
Huberman E, Glesne D, Collart F. Huberman E, et al. Adv Exp Med Biol. 1994;370:741-6. doi: 10.1007/978-1-4615-2584-4_155. Adv Exp Med Biol. 1994. PMID: 7661012 Review. No abstract available. - Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
Zimmermann AG, Gu JJ, Laliberté J, Mitchell BS. Zimmermann AG, et al. Prog Nucleic Acid Res Mol Biol. 1998;61:181-209. doi: 10.1016/s0079-6603(08)60827-2. Prog Nucleic Acid Res Mol Biol. 1998. PMID: 9752721 Review. - Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines.
Konno Y, Natsumeda Y, Nagai M, Yamaji Y, Ohno S, Suzuki K, Weber G. Konno Y, et al. J Biol Chem. 1991 Jan 5;266(1):506-9. J Biol Chem. 1991. PMID: 1670768 - Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions.
Liu Y, Riley LB, Bohn SA, Boice JA, Stadler PB, Sherley JL. Liu Y, et al. J Cell Physiol. 1998 Nov;177(2):364-76. doi: 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9. J Cell Physiol. 1998. PMID: 9766533
Cited by
- IMPDH-Based Cytoophidium Structures as Potential Theranostics in Cancer.
Keppeke GD, Andrade LEC, Barcelos D, Fernandes M, Landman G. Keppeke GD, et al. Mol Ther. 2020 Jul 8;28(7):1557-1558. doi: 10.1016/j.ymthe.2020.06.006. Epub 2020 Jun 11. Mol Ther. 2020. PMID: 32534605 Free PMC article. No abstract available. - Mycoplasmas and cancer: focus on nucleoside metabolism.
Vande Voorde J, Balzarini J, Liekens S. Vande Voorde J, et al. EXCLI J. 2014 Mar 27;13:300-22. eCollection 2014. EXCLI J. 2014. PMID: 26417262 Free PMC article. Review. - Modulating pyrimidine ribonucleotide levels for the treatment of cancer.
Mollick T, Laín S. Mollick T, et al. Cancer Metab. 2020 Oct 4;8:12. doi: 10.1186/s40170-020-00218-5. eCollection 2020. Cancer Metab. 2020. PMID: 33020720 Free PMC article. Review. - IMPDH2 promotes cell proliferation and epithelial-mesenchymal transition of non-small cell lung cancer by activating the Wnt/β-catenin signaling pathway.
Xu H, Ma H, Zha L, Li Q, Yang G, Pan H, Fei X, Xu X, Xing C, Zhang L. Xu H, et al. Oncol Lett. 2020 Nov;20(5):219. doi: 10.3892/ol.2020.12082. Epub 2020 Sep 9. Oncol Lett. 2020. PMID: 32963625 Free PMC article. - The targets of curcumin.
Zhou H, Beevers CS, Huang S. Zhou H, et al. Curr Drug Targets. 2011 Mar 1;12(3):332-47. doi: 10.2174/138945011794815356. Curr Drug Targets. 2011. PMID: 20955148 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources